• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Neuroendocrine alterations in the fragile X mouse.

作者信息

El Idrissi Abdeslem, Yan Xin, L'Amoreaux William, Brown W Ted, Dobkin Carl

机构信息

Department of Biology, College of Staten Island, Staten Island, NY, USA.

出版信息

Results Probl Cell Differ. 2012;54:201-21. doi: 10.1007/978-3-642-21649-7_11.

DOI:10.1007/978-3-642-21649-7_11
PMID:22009354
Abstract

The expression of GABA(A) receptors in the fragile X mouse brain is significantly downregulated. We additionally found that the expression of somatostatin and voltage-sensitive calcium channels (VSCCs) is also reduced. GABA(A) and the VSCCs, through a synergistic interaction, perform a critical role in mediating activity-dependent developmental processes. In the developing brain, GABA is excitatory and its actions are mediated through GABA(A) receptors. Subsequent to GABA-mediated depolarization, the VSCCs are activated and intracellular calcium is increased, which mediates gene transcription and other cellular events. GABAergic excitation mediated through GABA(A) receptors and the subsequent activation of the VSCCs are critically important for the establishment of neuronal connectivity within immature neuronal networks. Data from our laboratories suggest that there is a dysregulation of axonal pathfinding during development in the fragile X mouse brain and that this is likely due to a dysregulation of the synergistic interactions of GABA and VSCC. Thus, we hypothesize that the altered expression of these critical channels in the early stages of brain development leads to altered activity-dependent gene expression that may potentially lead to the developmental delay characteristic of the fragile X syndrome.

摘要

相似文献

1
Neuroendocrine alterations in the fragile X mouse.
Results Probl Cell Differ. 2012;54:201-21. doi: 10.1007/978-3-642-21649-7_11.
2
Early developmental alterations in GABAergic protein expression in fragile X knockout mice.脆性 X 敲除小鼠中 GABA 能蛋白表达的早期发育改变。
Neuropharmacology. 2010 Sep;59(3):167-71. doi: 10.1016/j.neuropharm.2010.05.002. Epub 2010 May 12.
3
Neuro-endocrine basis for altered plasma glucose homeostasis in the Fragile X mouse.脆性 X 小鼠血浆葡萄糖稳态改变的神经内分泌基础。
J Biomed Sci. 2010 Aug 24;17 Suppl 1(Suppl 1):S8. doi: 10.1186/1423-0127-17-S1-S8.
4
Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.癫痫易感性脆性X小鼠中GABA(A)受体表达降低。
Neurosci Lett. 2005 Apr 4;377(3):141-6. doi: 10.1016/j.neulet.2004.11.087. Epub 2004 Dec 23.
5
Decreased expression of the GABAA receptor in fragile X syndrome.脆性X综合征中γ-氨基丁酸A型受体表达降低。
Brain Res. 2006 Nov 22;1121(1):238-45. doi: 10.1016/j.brainres.2006.08.115. Epub 2006 Oct 16.
6
Pharmacological treatment of fragile X syndrome with GABAergic drugs in a knockout mouse model.使用 GABA 能药物治疗脆性 X 综合征的药物治疗。
Behav Brain Res. 2012 Apr 1;229(1):244-9. doi: 10.1016/j.bbr.2012.01.031. Epub 2012 Jan 21.
7
Developmental changes in expression of inhibitory neuronal proteins in the Fragile X Syndrome mouse basolateral amygdala.脆性 X 综合征小鼠基底外侧杏仁核中抑制性神经元蛋白表达的发育变化。
Brain Res. 2013 Nov 6;1537:69-78. doi: 10.1016/j.brainres.2013.08.052. Epub 2013 Sep 2.
8
Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome.脆性X智力低下1基因缺陷小鼠(脆性X综合征的病理模型)大脑中氧化应激增强标志物、抗氧化剂改变及NADPH氧化酶激活情况
Eur J Neurosci. 2007 Dec;26(11):3169-80. doi: 10.1111/j.1460-9568.2007.05939.x. Epub 2007 Nov 14.
9
Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model.表达谱分析表明,在脆性X基因敲除小鼠模型中,γ-氨基丁酸A(GABA(A))受体δ亚基表达不足。
Neurobiol Dis. 2006 Feb;21(2):346-57. doi: 10.1016/j.nbd.2005.07.017. Epub 2005 Sep 30.
10
Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS).脆性X综合征及脆性X相关震颤/共济失调综合征(FXTAS)动物模型中γ-氨基丁酸能系统的表达
Brain Res. 2009 Feb 9;1253:176-83. doi: 10.1016/j.brainres.2008.11.075. Epub 2008 Dec 3.

引用本文的文献

1
Fragile X targeted pharmacotherapy: lessons learned and future directions.脆性X综合征靶向药物治疗:经验教训与未来方向。
J Neurodev Disord. 2017 Jun 12;9:7. doi: 10.1186/s11689-017-9186-9. eCollection 2017.
2
Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.阿坎酸在脆性X综合征小鼠模型中的作用:对自发皮质活动、ERK1/2激活、运动行为和焦虑的调节
J Neurodev Disord. 2017 Jun 12;9:6. doi: 10.1186/s11689-017-9184-y. eCollection 2017.
3
Pharmacotherapy for Fragile X Syndrome: Progress to Date.
脆性X综合征的药物治疗:迄今的进展
Drugs. 2016 Mar;76(4):431-45. doi: 10.1007/s40265-016-0542-y.
4
Emerging pharmacologic treatment options for fragile X syndrome.脆性X综合征新出现的药物治疗选择
Appl Clin Genet. 2015 Apr 7;8:75-93. doi: 10.2147/TACG.S35673. eCollection 2015.
5
Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.坎培拉对脆性 X 综合征青少年行为和脑源性神经营养因子的影响:一项开放标签研究。
Psychopharmacology (Berl). 2013 Jul;228(1):75-84. doi: 10.1007/s00213-013-3022-z. Epub 2013 Feb 24.